Envista Holdings (NVST) Stock Price

Envista Holdings Price

NYSE·CLOSED
23.64
​
Market closed

Over the last 11 years Envista Holdings grew revenue by 2.0% annually, reaching 2.72 B USD. Earnings per share have declined at 13.0% per year over the last 11 years. For Envista Holdings, the net margin of 1.7% is down versus 13.6% a few years ago. The consensus 12-month price target for Envista Holdings is 29.00 USD, about 22.7% above where the stock trades today. Of 22 analysts, 12 rate the stock a buy — an overall Buy consensus.

Envista Holdings stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Envista Holdings business model & stock analysis

Envista Holdings Corp is a globally operating company that specializes in the development and manufacturing of innovative dental products. The company is not well-known despite playing an important role in the dental industry and being headquartered in California. The history of Envista Holdings Corp started in 2004 when it was founded by Danaher Corporation to enter the dental products market. Since then, the company has made several acquisitions to expand its presence in the market and diversify its product line. Envista Holdings Corp was finally taken public in 2019 and has since been an independent company. Envista's business model is based on manufacturing and selling products that support dentists in their work. The company is divided into three business segments: KaVo Kerr, Nobel Biocare, and Ormco. Each of these segments specializes in specific aspects of dentistry and offers corresponding products and solutions. Envista's KaVo Kerr segment produces and distributes diagnostic products, especially digital imaging, as well as dental chairs, handpieces, and instruments. Nobel Biocare is a leading developer and manufacturer of innovative dental implant systems. Ormco focuses on manufacturing braces and aligners that meet the highest standards. Envista's products are known for their high quality and precision, which strengthens the trust of dentists in the company. Envista aims to offer a comprehensive range of products to meet the needs of dentists in all areas. The company also places great importance on training and supporting its customers to ensure they can make optimal use of Envista's products. In addition to its products, the company also offers services that aim to make dentists' lives easier. These include training, technical support, and marketing tools to support dentists in growing their businesses. In recent years, Envista has undergone rapid development through acquisitions of companies such as Ormco, Nobel Biocare, and KaVo Kerr, in order to achieve a broader product range and a larger customer base. Overall, the company employs more than 12,000 people worldwide. To stay competitive, Envista has also increased its investment in research and development. The goal is to constantly provide new products and technologies to elevate dentistry to a higher level. To achieve this, the company works closely with dentists, researchers, and other experts in the field of dentistry. In conclusion, Envista Holdings Corp is an important player in the dental products and services industry. The company specializes in selling high-quality and innovative products. Thanks to its focus on developing products that meet customer requirements, the company has strengthened its position in the market and experienced rapid growth in recent years.

Frequently asked questions about Envista Holdings

Envista Holdings Corp faces competition from other major players in the dental industry, including Dentsply Sirona Inc., Straumann Holding AG, and Henry Schein, Inc. These competitors offer a similar range of dental products, solutions, and services, which directly competes with Envista Holdings Corp. However, Envista Holdings Corp distinguishes itself through its innovative solutions, cutting-edge technology, and a strong reputation for quality and customer satisfaction.

Envista Holdings Corp is primarily active in the dental industry. As a global leader in dental products and technologies, Envista offers a wide range of solutions for dental professionals and patients. With its portfolio of trusted brands, including KaVo Kerr, Nobel Biocare, and Ormco, Envista aims to improve patient care and enhance dental outcomes. By focusing on innovation, collaboration, and customer satisfaction, Envista continues to drive advancements in dentistry, making a significant impact in the industry worldwide.

Envista Holdings Corp is a dental products and technologies company. Its business model revolves around providing a comprehensive range of solutions to dental professionals worldwide. This includes advanced diagnostic and treatment products, software, and services necessary for efficient dental practice management. Additionally, Envista offers orthodontics, implant dentistry, and digital imaging technologies to enhance patient care. The company aims to continuously innovate and collaborate with dental professionals to improve oral healthcare outcomes. Envista Holdings Corp remains committed to delivering high-quality products and solutions that meet the diverse needs of dental practices, making it a leading player in the dental industry.

Envista Holdings Corp is a leading global dental product and technology company. Established in 2019, it was previously a subsidiary of Danaher Corporation. Envista operates in three main segments: Specialty Products, Equipment & Consumables, and Dental Technologies. With a rich history in the dental industry, the company offers a comprehensive portfolio of innovative dental solutions, including dental implants, orthodontics, imaging systems, and software. Envista continuously strives to enhance patient care by providing advanced technologies and products to dental professionals worldwide. As a trusted name in the dental field, Envista Holdings Corp has built a solid reputation for delivering high-quality dental solutions that improve oral health outcomes.

Envista Holdings Corp has achieved several significant milestones since its inception. The company has successfully established itself as a global leader in the dental industry, offering a comprehensive range of products and services. Envista Holdings Corp has consistently demonstrated strong financial performance, leading to its inclusion in the S&P MidCap 400 index. The company's commitment to innovation and research has resulted in numerous patents and industry accolades. Furthermore, Envista Holdings Corp has expanded its market presence by acquiring leading dental companies and leveraging strategic partnerships. These accomplishments showcase the company's dedication to evolving dental care and driving growth in the industry.

Envista Holdings Corp is primarily present in the United States, where its headquarters are located. As a globally recognized company, Envista is also present in various international markets. With a strong global presence, Envista serves customers and clients across Europe, Asia-Pacific, Latin America, and other regions. This diversified geographical presence allows Envista to offer its innovative solutions, products, and services to a wide range of customers worldwide.

Envista Holdings Corp represents a commitment to excellence, innovation, and patient care. With a strong corporate philosophy focused on empowering healthcare professionals, Envista aims to provide high-quality dental products, solutions, and services. The company's values include integrity, teamwork, and a dedication to improving oral health worldwide. Envista's innovative mindset drives continuous advancements in dental technology, enabling dental professionals to deliver optimal patient outcomes. By promoting transparency, collaboration, and sustainable practices, Envista upholds its corporate philosophy of delivering value to patients, customers, and shareholders.

Analysts currently set an average price target of 29.14 USD for the Envista Holdings stock (median: 29.00 USD), implying +23.0 % versus the latest price. The consensus is based on 22 analyst ratings.

22 analysts currently rate the Envista Holdings stock: 12 recommend buying, 10 holding and 0 selling. For 2026, analysts expect Envista Holdings to generate revenue of 2.87 B USD and earnings per share of 1.54 USD.

Converted at the current exchange rate, the Envista Holdings share trades at 21.54 EUR (23.64 USD).

The Envista Holdings share (NVST) is listed on 5 stock exchanges, including: NYSE (NVST), XETRA (0HV.DE), Frankfurt (0HV.F), München (0HV.MU), Düsseldorf (0HV.DU).

Envista Holdings Corp is a leading provider of products and services in the field of dental equipment and technology. The company offers equipment and implant systems, digital imaging solutions, precision instruments, and services for dentists and dental technicians worldwide. The company operates in three main business segments: 1. Kavo Kerr: Kavo Kerr is the world's leading provider of dental handpieces and angles, instruments, hygiene and sterilization equipment, consumables, and related software. 2. Imaging: The imaging segment includes the brands KaVo, Gendex, i-CAT, and Instrumentarium. These brands offer digital imaging solutions for orthodontics, endodontics, restorative dentistry, and periodontics. 3. Nobel Biocare: The Nobel Biocare segment specializes in implant systems and related products, serving both dentists and dental technicians. Envista Holdings Corp has made a name for itself through its innovation, high-quality products and services, and strong customer focus. The company continuously introduces new products and technologies and invests in research and development to provide its customers with the best possible quality and efficiency. One of Envista Holdings Corp's products, for example, is the KaVo NOMAD Pro 2, a portable X-ray device that improves workflow in the dental practice and offers patients greater comfort. Another product is the i-CAT FLX, an advanced 3D imaging platform for orthodontics that enables precise diagnosis and planning. With its wide range of products and excellent customer service, Envista Holdings Corp is well positioned to further expand and diversify its business in the dental industry. Overall, the business model of Envista Holdings Corp is focused on meeting the needs of dentists and dental technicians and offering them high-quality products and services to ensure efficient and high-quality patient care.

The expected revenue of Envista Holdings is 2.87 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Envista Holdings is 255.56 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Envista Holdings is currently 15.36. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Envista Holdings stock.

The price-to-sales ratio (P/S) of Envista Holdings is currently 1.37. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Envista Holdings stock.

The Eulerpool Quality Score for Envista Holdings is 1/10.

The ISIN of Envista Holdings is US29415F1049. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Envista Holdings is A2PN69. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Envista Holdings is NVST. The ticker symbol is used to trade Envista Holdings shares on the stock exchange.

Fair ValueTerminal
22.22 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
226,625.00 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Sep 18, 2019
ISIN
US29415F1049
Cusip
29415F104
Sedol
BK63SF3
Market capitalization
3.87 B USDMid Cap
52-Week Range
PEG
13.50
P/E ratio
P/Ee 2026
15.15
P/Ee 2027
14.13
P/Ee 2028
12.99
P/Ee 2029
11.92
P/S
P/Se
1.37
EV/EBIT
13.50
P/B Ratio
1.25
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
1.00 %
Last updated Nov 19, 2026, 3:40 AM

Envista Holdings Ticker

DÜSSELDORF · 0HV.DUFRANKFURT · 0HV.FMUNICH · 0HV.MUNEW YORK · NVSTXETRA · 0HV.DE

Envista Holdings FIGI

NVST:US · BBG00LN4B5N0NVST:UA · BBG00LN4B5P8NVST:UC · BBG00LN4B5Q7NVST:UN · BBG00LN4B5S5NVST:UP · BBG00LN4B5T4NVST:UB · BBG00LN4B5W0NVST:UT · BBG00LN4B5X9NVST:UM · BBG00LN4B5Y8NVST:UX · BBG00LN4B5Z7NVST:UD · BBG00LN4B649NVST:UF · BBG00LN4B676NVST:VY · BBG00LN4B685